Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Assets: 2011-2025

Historic Return on Assets for Catalyst Pharmaceuticals (CPRX) over the last 12 years, with Sep 2025 value amounting to 0.21%.

  • Catalyst Pharmaceuticals' Return on Assets rose 4.00% to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year increase of 4.00%. This contributed to the annual value of 0.25% for FY2024, which is 11.00% up from last year.
  • As of Q3 2025, Catalyst Pharmaceuticals' Return on Assets stood at 0.21%, which was down 3.08% from 0.22% recorded in Q2 2025.
  • Catalyst Pharmaceuticals' Return on Assets' 5-year high stood at 0.37% during Q1 2021, with a 5-year trough of 0.08% in Q2 2024.
  • In the last 3 years, Catalyst Pharmaceuticals' Return on Assets had a median value of 0.20% in 2024 and averaged 0.18%.
  • Its Return on Assets has fluctuated over the past 5 years, first fell by 27bps in 2021, then climbed by 14bps in 2025.
  • Quarterly analysis of 5 years shows Catalyst Pharmaceuticals' Return on Assets stood at 0.17% in 2021, then grew by 6bps to 0.23% in 2022, then declined by 10bps to 0.13% in 2023, then increased by 7bps to 0.20% in 2024, then increased by 4bps to 0.21% in 2025.
  • Its last three reported values are 0.21% in Q3 2025, 0.22% for Q2 2025, and 0.22% during Q1 2025.